Europe Human Prothrombin Complex Market Size, Status and Forecast 2014-2026

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • The Human Prothrombin Complex market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 6.1% during the forecast period. Focusing on the Europe market, this report analyzes the specific consumption structure, such as types and end users. In order to present the status of the circulation of this product in different Europe countries, this report covers top export and import countries to confirm the potential markets. Leading countries such as Germany, UK, France, Italy, Spain, Poland, Russia, Switzerland, Turkey, Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden), Benelux (Belgium, Netherlands, and Luxembourg), Baltic States (Estonia, Latvia, and Lithuania) and other countries, the market status and consumption potential of these countries are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Europe Human Prothrombin Complex Market Segmentations:

    By Player:

    • Octapharma

    • CSL

    • Shire

    • Hualan Biological

    • Meheco Xinxing Pharma

    • Grifols

    By Type:

    • 500 IU/Vial

    • 600 IU/Vial

    • 1000 IU/Vial

    • Others

    By End-User:

    • Hemophilia B

    • Vitamin K Deficiency

    • Others

    By Region:

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Poland

    • Russia

    • Switzerland

    • Turkey

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

      • Denmark

      • Finland

      • Norway

      • Sweden

      • Iceland

    • Benelux (Belgium, Netherlands, and Luxembourg)

      • Belgium

      • Netherlands

      • Luxembourg

    • Baltic States (Estonia, Latvia, and Lithuania)

      • Estonia

      • Latvia

      • Lithuania

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Human Prothrombin Complex Market

    • 1.3 Market Segment by Type

    • 1.3.1 Europe Human Prothrombin Complex Market Size and Growth Rate of 500 IU/Vial from 2014 to 2026

    • 1.3.2 Europe Human Prothrombin Complex Market Size and Growth Rate of 600 IU/Vial from 2014 to 2026

    • 1.3.3 Europe Human Prothrombin Complex Market Size and Growth Rate of 1000 IU/Vial from 2014 to 2026

    • 1.3.4 Europe Human Prothrombin Complex Market Size and Growth Rate of Others from 2014 to 2026

    • 1.4 Market Segment by Application

    • 1.4.1 Europe Human Prothrombin Complex Market Size and Growth Rate of Hemophilia B from 2014 to 2026

    • 1.4.2 Europe Human Prothrombin Complex Market Size and Growth Rate of Vitamin K Deficiency from 2014 to 2026

    • 1.4.3 Europe Human Prothrombin Complex Market Size and Growth Rate of Others from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Germany Human Prothrombin Complex Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 UK Human Prothrombin Complex Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 France Human Prothrombin Complex Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Italy Human Prothrombin Complex Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Spain Human Prothrombin Complex Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Poland Human Prothrombin Complex Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Russia Human Prothrombin Complex Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Switzerland Human Prothrombin Complex Market Size and Growth Rate from 2014 to 2026

      • 1.5.9 Turkey Human Prothrombin Complex Market Size and Growth Rate from 2014 to 2026

      • 1.5.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Human Prothrombin Complex Market Size and Growth Rate from 2014 to 2026

      • 1.5.11 Benelux (Belgium, Netherlands, and Luxembourg) Human Prothrombin Complex Market Size and Growth Rate from 2014 to 2026

      • 1.5.12 Baltic States (Estonia, Latvia, and Lithuania) Human Prothrombin Complex Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Human Prothrombin Complex Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Venders

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Human Prothrombin Complex by Major Types

      • 3.4.1 Market Size and Growth Rate of 500 IU/Vial

      • 3.4.2 Market Size and Growth Rate of 600 IU/Vial

      • 3.4.3 Market Size and Growth Rate of 1000 IU/Vial

      • 3.4.4 Market Size and Growth Rate of Others

    4 Segmentation of Human Prothrombin Complex Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Human Prothrombin Complex by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Hemophilia B for Construction

      • 4.4.2 Market Size and Growth Rate of Vitamin K Deficiency for Construction

      • 4.4.3 Market Size and Growth Rate of Others for Construction

    5 Market Analysis by Major Regions

    • 5.1 Europe Human Prothrombin Complex Production Analysis by Top Regions

    • 5.2 Europe Human Prothrombin Complex Consumption Analysis by Top Regions

    • 5.3 Europe Human Prothrombin Complex Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 Germany Human Prothrombin Complex Production, Import, Consumption and Export Analysis

      • 5.3.2 UK Human Prothrombin Complex Production, Import, Consumption and Export Analysis

      • 5.3.3 France Human Prothrombin Complex Production, Import, Consumption and Export Analysis

      • 5.3.4 Italy Human Prothrombin Complex Production, Import, Consumption and Export Analysis

      • 5.3.5 Spain Human Prothrombin Complex Production, Import, Consumption and Export Analysis

      • 5.3.6 Poland Human Prothrombin Complex Production, Import, Consumption and Export Analysis

      • 5.3.7 Russia Human Prothrombin Complex Production, Import, Consumption and Export Analysis

      • 5.3.8 Switzerland Human Prothrombin Complex Production, Import, Consumption and Export Analysis

      • 5.3.9 Turkey Human Prothrombin Complex Production, Import, Consumption and Export Analysis

      • 5.3.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Human Prothrombin Complex Production, Import, Consumption and Export Analysis

      • 5.3.11 Benelux (Belgium, Netherlands, and Luxembourg) Human Prothrombin Complex Production, Import, Consumption and Export Analysis

      • 5.3.12 Baltic States (Estonia, Latvia, and Lithuania) Human Prothrombin Complex Production, Import, Consumption and Export Analysis

    6 Product Circulation of Human Prothrombin Complex Market among Top Countries

    • 6.1 Top 5 Export Countries in Human Prothrombin Complex Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in Human Prothrombin Complex Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in Human Prothrombin Complex Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Human Prothrombin Complex Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in Human Prothrombin Complex Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in Human Prothrombin Complex Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. Germany Human Prothrombin Complex Landscape Analysis

    • 7.1 Germany Human Prothrombin Complex Landscape Analysis by Major Types

    • 7.2 Germany Human Prothrombin Complex Landscape Analysis by Major End-Users

    8. UK Human Prothrombin Complex Landscape Analysis

    • 8.1 UK Human Prothrombin Complex Landscape Analysis by Major Types

    • 8.2 UK Human Prothrombin Complex Landscape Analysis by Major End-Users

    9. France Human Prothrombin Complex Landscape Analysis

    • 9.1 France Human Prothrombin Complex Landscape Analysis by Major Types

    • 9.2 France Human Prothrombin Complex Landscape Analysis by Major End-Users

    10. Italy Human Prothrombin Complex Landscape Analysis

    • 10.1 Italy Human Prothrombin Complex Landscape Analysis by Major Types

    • 10.2 Italy Human Prothrombin Complex Landscape Analysis by Major End-Users

    11. Spain Human Prothrombin Complex Landscape Analysis

    • 11.1 Spain Human Prothrombin Complex Landscape Analysis by Major Types

    • 11.2 Spain Human Prothrombin Complex Landscape Analysis by Major End-Users

    12. Poland Human Prothrombin Complex Landscape Analysis

    • 12.1 Poland Human Prothrombin Complex Landscape Analysis by Major Types

    • 12.2 Poland Human Prothrombin Complex Landscape Analysis by Major End-Users

    13. Russia Human Prothrombin Complex Landscape Analysis

    • 13.1 Russia Human Prothrombin Complex Landscape Analysis by Major Types

    • 13.2 Russia Human Prothrombin Complex Landscape Analysis by Major End-Users

    14. Switzerland Human Prothrombin Complex Landscape Analysis

    • 14.1 Switzerland Human Prothrombin Complex Landscape Analysis by Major Types

    • 14.2 Switzerland Human Prothrombin Complex Landscape Analysis by Major End-Users

    15. Turkey Human Prothrombin Complex Landscape Analysis

    • 15.1 Turkey Human Prothrombin Complex Landscape Analysis by Major Types

    • 15.2 Turkey Human Prothrombin Complex Landscape Analysis by Major End-Users

    16. Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Human Prothrombin Complex Landscape Analysis

    • 16.1 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Human Prothrombin Complex Landscape Analysis by Major Types

    • 16.2 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Human Prothrombin Complex Landscape Analysis by Major End-Users

    • 16.3 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Human Prothrombin Complex Landscape Analysis by Top Countries

      • 16.3.1 Denmark Human Prothrombin Complex Market Volume and Growth Rate

      • 16.3.2 Finland Human Prothrombin Complex Market Volume and Growth Rate

      • 16.3.3 Norway Human Prothrombin Complex Market Volume and Growth Rate

      • 16.3.4 Sweden Human Prothrombin Complex Market Volume and Growth Rate

      • 16.3.6 Iceland Human Prothrombin Complex Market Volume and Growth Rate

    17 Benelux (Belgium, Netherlands, and Luxembourg) Human Prothrombin Complex Landscape Analysis

    • 17.1 Benelux (Belgium, Netherlands, and Luxembourg) Human Prothrombin Complex Landscape Analysis by Major Types

    • 17.2 Benelux (Belgium, Netherlands, and Luxembourg) Human Prothrombin Complex Landscape Analysis by Major End-Users

    • 17.3 Benelux (Belgium, Netherlands, and Luxembourg) Human Prothrombin Complex Landscape Analysis by Top Countries

      • 17.3.1 Belgium Human Prothrombin Complex Market Volume and Growth Rate

      • 17.3.2 Netherlands Human Prothrombin Complex Market Volume and Growth Rate

      • 17.3.3 Luxembourg Human Prothrombin Complex Market Volume and Growth Rate

    18 Baltic States (Estonia, Latvia, and Lithuania) Human Prothrombin Complex Landscape Analysis

    • 18.1 Baltic States (Estonia, Latvia, and Lithuania) Human Prothrombin Complex Landscape Analysis by Major Types

    • 18.2 Baltic States (Estonia, Latvia, and Lithuania) Human Prothrombin Complex Landscape Analysis by Major End-Users

    • 18.3 Baltic States (Estonia, Latvia, and Lithuania) Human Prothrombin Complex Landscape Analysis by Top Countries

      • 18.3.1 Estonia Human Prothrombin Complex Market Volume and Growth Rate

      • 18.3.2 Latvia Human Prothrombin Complex Market Volume and Growth Rate

      • 18.3.3 Lithuania Human Prothrombin Complex Market Volume and Growth Rate

    19 Major Players Profiles

    • 19.1 Octapharma

      • 19.1.1 Octapharma Company Profile and Development Status

      • 19.1.2 Market Performance

      • 19.1.3 Product and Service Introduction

    • 19.2 CSL

      • 19.2.1 CSL Company Profile and Development Status

      • 19.2.2 Market Performance

      • 19.2.3 Product and Service Introduction

    • 19.3 Shire

      • 19.3.1 Shire Company Profile and Development Status

      • 19.3.2 Market Performance

      • 19.3.3 Product and Service Introduction

    • 19.4 Hualan Biological

      • 19.4.1 Hualan Biological Company Profile and Development Status

      • 19.4.2 Market Performance

      • 19.4.3 Product and Service Introduction

    • 19.5 Meheco Xinxing Pharma

      • 19.5.1 Meheco Xinxing Pharma Company Profile and Development Status

      • 19.5.2 Market Performance

      • 19.5.3 Product and Service Introduction

    • 19.6 Grifols

      • 19.6.1 Grifols Company Profile and Development Status

      • 19.6.2 Market Performance

      • 19.6.3 Product and Service Introduction

    The List of Tables and Figures (Totals 123 Figures and 200 Tables)

    • Figure Product Picture

    • Figure Human Prothrombin Complex Market Size and Growth Rate of 500 IU/Vial Market, 2015 - 2026 (USD Million)

    • Figure Human Prothrombin Complex Market Size and Growth Rate of 600 IU/Vial Market, 2015 - 2026 (USD Million)

    • Figure Human Prothrombin Complex Market Size and Growth Rate of 1000 IU/Vial Market, 2015 - 2026 (USD Million)

    • Figure Human Prothrombin Complex Market Size and Growth Rate of Others Market, 2015 - 2026 (USD Million)

    • Figure Human Prothrombin Complex Market Size and Growth Rate of Hemophilia B from 2014 to 2026

    • Figure Human Prothrombin Complex Market Size and Growth Rate of Vitamin K Deficiency from 2014 to 2026

    • Figure Human Prothrombin Complex Market Size and Growth Rate of Others from 2014 to 2026

    • Figure Germany Human Prothrombin Complex Market Size and Growth Rate from 2014 to 2026

    • Figure UK Human Prothrombin Complex Market Size and Growth Rate from 2014 to 2026

    • Figure France Human Prothrombin Complex Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Human Prothrombin Complex Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Human Prothrombin Complex Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Human Prothrombin Complex Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Human Prothrombin Complex Market Size and Growth Rate from 2014 to 2026

    • Figure Switzerland Human Prothrombin Complex Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Human Prothrombin Complex Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Human Prothrombin Complex Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Human Prothrombin Complex Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Human Prothrombin Complex Market Size and Growth Rate from 2014 to 2026

    • Figure Denmark Human Prothrombin Complex Market Size and Growth Rate from 2014 to 2026

    • Figure Finland Human Prothrombin Complex Market Size and Growth Rate from 2014 to 2026

    • Figure Norway Human Prothrombin Complex Market Size and Growth Rate from 2014 to 2026

    • Figure Sweden Human Prothrombin Complex Market Size and Growth Rate from 2014 to 2026

    • Figure Iceland Human Prothrombin Complex Market Size and Growth Rate from 2014 to 2026

    • Figure Benelux (Belgium, Netherlands, and Luxembourg) Human Prothrombin Complex Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Human Prothrombin Complex Market Size and Growth Rate from 2014 to 2026

    • Figure Netherlands Human Prothrombin Complex Market Size and Growth Rate from 2014 to 2026

    • Figure Luxembourg Human Prothrombin Complex Market Size and Growth Rate from 2014 to 2026

    • Figure Baltic States (Estonia, Latvia, and Lithuania) Human Prothrombin Complex Market Size and Growth Rate from 2014 to 2026

    • Figure Estonia Human Prothrombin Complex Market Size and Growth Rate from 2014 to 2026

    • Figure Latvia Human Prothrombin Complex Market Size and Growth Rate from 2014 to 2026

    • Figure Lithuania Human Prothrombin Complex Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Human Prothrombin Complex Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Human Prothrombin Complex

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Human Prothrombin Complex by Different Types from 2014 to 2026

    • Table Consumption Share of Human Prothrombin Complex by Different Types from 2014 to 2026

    • Figure Human Prothrombin Complex Market Size and Growth Rate of 500 IU/Vial Market, 2015 - 2026 (USD Million)

    • Figure Human Prothrombin Complex Market Size and Growth Rate of 600 IU/Vial Market, 2015 - 2026 (USD Million)

    • Figure Human Prothrombin Complex Market Size and Growth Rate of 1000 IU/Vial Market, 2015 - 2026 (USD Million)

    • Figure Human Prothrombin Complex Market Size and Growth Rate of Others Market, 2015 - 2026 (USD Million)

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Human Prothrombin Complex by Different End-Users from 2014 to 2026

    • Table Consumption Share of Human Prothrombin Complex by Different End-Users from 2014 to 2026

    • Figure Human Prothrombin Complex Market Size and Growth Rate of Hemophilia B from 2014 to 2026

    • Figure Human Prothrombin Complex Market Size and Growth Rate of Vitamin K Deficiency from 2014 to 2026

    • Figure Human Prothrombin Complex Market Size and Growth Rate of Others from 2014 to 2026

    • Table Europe Human Prothrombin Complex Production by Major Regions

    • Table Europe Human Prothrombin Complex Production Share by Major Regions

    • Figure Europe Human Prothrombin Complex Production Share by Major Countries and Regions in 2014

    • Table Europe Human Prothrombin Complex Consumption by Major Regions

    • Table Europe Human Prothrombin Complex Consumption Share by Major Regions

    • Table Germany Human Prothrombin Complex Production, Import, Consumption and Export Analysis

    • Table UK Human Prothrombin Complex Production, Import, Consumption and Export Analysis

    • Table France Human Prothrombin Complex Production, Import, Consumption and Export Analysis

    • Table Italy Human Prothrombin Complex Production, Import, Consumption and Export Analysis

    • Table Spain Human Prothrombin Complex Production, Import, Consumption and Export Analysis

    • Table Poland Human Prothrombin Complex Production, Import, Consumption and Export Analysis

    • Table Russia Human Prothrombin Complex Production, Import, Consumption and Export Analysis

    • Table Switzerland Human Prothrombin Complex Production, Import, Consumption and Export Analysis

    • Table Turkey Human Prothrombin Complex Production, Import, Consumption and Export Analysis

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Human Prothrombin Complex Production, Import, Consumption and Export Analysis

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Human Prothrombin Complex Production, Import, Consumption and Export Analysis

    • Table Baltic States (Estonia, Latvia, and Lithuania) Human Prothrombin Complex Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Human Prothrombin Complex Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Human Prothrombin Complex Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Human Prothrombin Complex Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Human Prothrombin Complex Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table Germany Human Prothrombin Complex Consumption by Types from 2014 to 2026

    • Table Germany Human Prothrombin Complex Consumption Share by Types from 2014 to 2026

    • Table Germany Human Prothrombin Complex Consumption by End-Users from 2014 to 2026

    • Table Germany Human Prothrombin Complex Consumption Share by End-Users from 2014 to 2026

    • Table UK Human Prothrombin Complex Consumption by Types from 2014 to 2026

    • Table UK Human Prothrombin Complex Consumption Share by Types from 2014 to 2026

    • Table UK Human Prothrombin Complex Consumption by End-Users from 2014 to 2026

    • Table UK Human Prothrombin Complex Consumption Share by End-Users from 2014 to 2026

    • Table France Human Prothrombin Complex Consumption by Types from 2014 to 2026

    • Table France Human Prothrombin Complex Consumption Share by Types from 2014 to 2026

    • Table France Human Prothrombin Complex Consumption by End-Users from 2014 to 2026

    • Table France Human Prothrombin Complex Consumption Share by End-Users from 2014 to 2026

    • Table Italy Human Prothrombin Complex Consumption by Types from 2014 to 2026

    • Table Italy Human Prothrombin Complex Consumption Share by Types from 2014 to 2026

    • Table Italy Human Prothrombin Complex Consumption by End-Users from 2014 to 2026

    • Table Italy Human Prothrombin Complex Consumption Share by End-Users from 2014 to 2026

    • Table Spain Human Prothrombin Complex Consumption by Types from 2014 to 2026

    • Table Spain Human Prothrombin Complex Consumption Share by Types from 2014 to 2026

    • Table Spain Human Prothrombin Complex Consumption by End-Users from 2014 to 2026

    • Table Spain Human Prothrombin Complex Consumption Share by End-Users from 2014 to 2026

    • Table Poland Human Prothrombin Complex Consumption by Types from 2014 to 2026

    • Table Poland Human Prothrombin Complex Consumption Share by Types from 2014 to 2026

    • Table Poland Human Prothrombin Complex Consumption by End-Users from 2014 to 2026

    • Table Poland Human Prothrombin Complex Consumption Share by End-Users from 2014 to 2026

    • Table Russia Human Prothrombin Complex Consumption by Types from 2014 to 2026

    • Table Russia Human Prothrombin Complex Consumption Share by Types from 2014 to 2026

    • Table Russia Human Prothrombin Complex Consumption by End-Users from 2014 to 2026

    • Table Russia Human Prothrombin Complex Consumption Share by End-Users from 2014 to 2026

    • Table Switzerland Human Prothrombin Complex Consumption by Types from 2014 to 2026

    • Table Switzerland Human Prothrombin Complex Consumption Share by Types from 2014 to 2026

    • Table Switzerland Human Prothrombin Complex Consumption by End-Users from 2014 to 2026

    • Table Switzerland Human Prothrombin Complex Consumption Share by End-Users from 2014 to 2026

    • Table Turkey Human Prothrombin Complex Consumption by Types from 2014 to 2026

    • Table Turkey Human Prothrombin Complex Consumption Share by Types from 2014 to 2026

    • Table Turkey Human Prothrombin Complex Consumption by End-Users from 2014 to 2026

    • Table Turkey Human Prothrombin Complex Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Human Prothrombin Complex Consumption by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Human Prothrombin Complex Consumption Share by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Human Prothrombin Complex Consumption by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Human Prothrombin Complex Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Human Prothrombin Complex Consumption by Major Countries from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Human Prothrombin Complex Consumption Share by Major Countries from 2014 to 2026

    • Figure Denmark Human Prothrombin Complex Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland Human Prothrombin Complex Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway Human Prothrombin Complex Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden Human Prothrombin Complex Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland Human Prothrombin Complex Market Volume and Growth Rate from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Human Prothrombin Complex Consumption by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Human Prothrombin Complex Consumption Share by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Human Prothrombin Complex Consumption by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Human Prothrombin Complex Consumption Share by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Human Prothrombin Complex Consumption by Major Countries from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Human Prothrombin Complex Consumption Share by Major Countries from 2014 to 2026

    • Figure Belgium Human Prothrombin Complex Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands Human Prothrombin Complex Market Volume and Growth Rate from 2014 to 2026

    • Figure Luxembourg Human Prothrombin Complex Market Volume and Growth Rate from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Human Prothrombin Complex Consumption by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Human Prothrombin Complex Consumption Share by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Human Prothrombin Complex Consumption by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Human Prothrombin Complex Consumption Share by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Human Prothrombin Complex Consumption by Major Countries from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Human Prothrombin Complex Consumption Share by Major Countries from 2014 to 2026

    • Figure Estonia Human Prothrombin Complex Market Volume and Growth Rate from 2014 to 2026

    • Figure Latvia Human Prothrombin Complex Market Volume and Growth Rate from 2014 to 2026

    • Figure Lithuania Countries Human Prothrombin Complex Market Volume and Growth Rate from 2014 to 2026

    • Table Octapharma Profiles

    • Table Octapharma Production, Value, Price, Gross Margin 2014-2019

    • Table Octapharma Product benchmarking

    • Table Octapharma Strategic initiatives

    • Table Octapharma SWOT analysis

    • Table CSL Profiles

    • Table CSL Production, Value, Price, Gross Margin 2014-2019

    • Table CSL Product benchmarking

    • Table CSL Strategic initiatives

    • Table CSL SWOT analysis

    • Table Shire Profiles

    • Table Shire Production, Value, Price, Gross Margin 2014-2019

    • Table Shire Product benchmarking

    • Table Shire Strategic initiatives

    • Table Shire SWOT analysis

    • Table Hualan Biological Profiles

    • Table Hualan Biological Production, Value, Price, Gross Margin 2014-2019

    • Table Hualan Biological Product benchmarking

    • Table Hualan Biological Strategic initiatives

    • Table Hualan Biological SWOT analysis

    • Table Meheco Xinxing Pharma Profiles

    • Table Meheco Xinxing Pharma Production, Value, Price, Gross Margin 2014-2019

    • Table Meheco Xinxing Pharma Product benchmarking

    • Table Meheco Xinxing Pharma Strategic initiatives

    • Table Meheco Xinxing Pharma SWOT analysis

    • Table Grifols Profiles

    • Table Grifols Production, Value, Price, Gross Margin 2014-2019

    • Table Grifols Product benchmarking

    • Table Grifols Strategic initiatives

    • Table Grifols SWOT analysis

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.